IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma | HTML
A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance | NEJM
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
Comparison of MGUS and multiple myeloma variants | Download Table
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study - Clinical Lymphoma, Myeloma and Leukemia
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Renal Manifestations of Plasma Cell Disorders - American Journal of Kidney Diseases
Monoclonals - an overview | ScienceDirect Topics
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal gammopathy of undetermined significance: A primary care guide | Cleveland Clinic Journal of Medicine
